Familial cancer · 2014
Diversity of the clinical presentation of the MMR gene biallelic mutations.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bougeard Gaëlle, Olivier-Faivre Laurence, Baert-Desurmont Stéphanie, Tinat Julie, Martin Cosette, Bouvignies Emilie, Vasseur Stéphanie, Huet Frédéric, Couillault Gérard, Vabres Pierre, Le Pessot Florence, Chapusot Caroline, Malka David, Bressac-de Paillerets Brigitte, Tosi Mario, Frebourg Thierry
Аннотация
Constitutional mismatch repair-deficiency, due to biallelic mutations of MMR genes, results in a tumour spectrum characterized by leukaemias, lymphomas, brain tumours and adenocarcinomas of the gastro-intestinal tract, occurring mostly in childhood. We report here two families illustrating the phenotypic diversity associated with biallelic MMR mutations. In the first family, two siblings developed six malignancies including glioblastoma, lymphoblastic T cell lymphoma, rectal and small bowel adenocarcinoma with onset as early as 6 years of age. We showed that this dramatic clinical presentation was due to the presence of two complex genomic PMS2 deletions in each patient predicted to result into complete PMS2 inactivation. In the second family, the index case presented with an early form of Lynch syndrome with colorectal adenocarcinomas at ages 17 and 20 years, and urinary tract tumours at the age of 25 years. We identified in this patient two MSH6 mutations corresponding to a frameshift deletion and an in frame deletion. The latter was not predicted to result into complete inactivation of MSH6. These reports show that the clinical expression of biallelic MMR mutations depends on the biological impact of the second MMR mutation and that, in clinical practice, the presence of a second MMR mutation located in trans should also be considered in patients suspected to present a Lynch syndrome with an unusual early-onset of tumours.
Предметные рубрики MeSH
AdenocarcinomaAdenosine TriphosphatasesAdolescentAge of OnsetChildColorectal Neoplasms, Hereditary NonpolyposisDNA Mismatch RepairDNA Repair EnzymesDNA-Binding ProteinsFemaleHaplotypesHumansLymphoma, T-CellMaleMicrosatellite InstabilityMismatch Repair Endonuclease PMS2MutationPedigreeRectal NeoplasmsYoung Adult